The scope of the Journal
Some seriously encouraging advances in cancer therapy research such as the re-engineering of immune cells to improve their efficacy fighting cancer cells and current innovation of targeting therapy applications to avoid off-target side effects from current chemotherapeutics. Hence, it becomes as important to have a robust publication platform for fast access to ideas and disseminate timely and open knowledge exchange of scholarly communication in order to build solid frontlines in the global war on cancer
The Cancer Therapy Letters provides an open-access vehicle for the speedy publication of peer-reviewed research findings in all aspects of immunology, immuno-biology, and immuno-genetics that aimed to investigate new therapies for cancer. The Journal will accept findings that include knowledge of immediate importance to investigators interested in cancer therapy development with soundness and novelty of used methods and applications.
The Journal publishes full-length research articles, rapid communications, correspondences and mini review/review articles. The Cancer Therapy Letters is a peer-reviewed journal that publishes original works FREE of charge.
Science frontiers publishing ©
Editor-in-chief
Editorial Board
Author Guidelines
Submit a Paper
Join Us
Science frontiers publishing ©
Science Frontiers Publishing 